4-Methyl-3,4-dihydro-2H-benzo[b][1,4]oxazine-7-carbonitrile | 566157-03-7

• 分子结构分类: 有机化合物 - 有机杂环化合物
• 英文名称: 4-Methyl-3,4-dihydro-2H-benzo[b][1,4]oxazine-7-carbonitrile
• 英文别名: 4-methyl-2,3-dihydro-1,4-benzoxazine-7-carbonitrile
• CAS: 566157-03-7
• 化学式: C₁₀H₁₀N₂O
• 分子量: 174.2
• InChiKey: MBNHXEGWTJIPMG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  36.3
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• [EN] COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES<br/>[FR] COMPOSÉS ET COMPOSITIONS POUR LE TRAITEMENT DE MALADIES PARASITAIRES
  申请人：IRM LLC

  公开号：WO2014078813A1

  公开（公告）日：2014-05-22

  The present invention provides compounds of formula I: [INSERT FORMULA HERE] or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease, such as malaria, caused by a Plasmodium parasite.

  本发明提供了式I的化合物：[在此插入公式]或其药学上可接受的盐、互变异构体或立体异构体，其中变量如本文所定义。本发明还提供了包含这种化合物的药物组合物以及使用这种化合物治疗、预防、抑制、改善或根除由疟原虫引起的疟疾等疾病的方法。
• [EN] ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE<br/>[FR] COMPOSÉS ANTIBACTÉRIENS ET LEURS MÉTHODES D'UTILISATION
  申请人：PTC THERAPEUTICS INC

  公开号：WO2013033258A1

  公开（公告）日：2013-03-07

  The present description relates to compounds and forms and pharmaceutical compositions thereof and methods for use thereof to treat or ameliorate bacterial infections caused by wild-type and multi-drug resistant Gram-negative and Gram-positive pathogens.

  本文描述了化合物、形式及其制药组合物以及使用方法，用于治疗或缓解由野生型和多重耐药革兰氏阴性和革兰氏阳性病原体引起的细菌感染。
• Acridone inhibitors of IMPDH enzyme
  申请人：——

  公开号：US20040053955A1

  公开（公告）日：2004-03-18

  Compounds having the formula (I), 1 wherein R 3 is selected from H, OH and NH 2 ; R 30 is selected from ═O and ═S; W is —C(═O)—, —S(═O)—, or —S(O) 2 —; or W may be —CH 2 — if X is —C(═O)—; X is selected from —CH 2 —, —N(R 4 )—, and —O—, except that when W is —CH 2 —, X is —C(═O)—; Y is a bond or —C(R 40 )(R 45 )—; Q is a linker; Z is optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, or heterocyclyl; and R 1 , R 2 , R 24 , and R 25 are as defined in the specification.

  化合物的化学式为（I），其中R3选自H，OH和NH2；R30选自═O和═S；W为—C(═O)—、—S(═O)—或—S(O)2—；如果X为—C(═O)—，则W可以为—CH2—；X选自— —、—N(R4)—和—O—，但当W为— —时，X为—C(═O)—；Y为键或—C(R40)(R45)—；Q为连接基；Z为可选的取代基的烷基、烯基、炔基、环烷基、芳基、杂芳基或杂环基；R1、R2、R24和R25如规范中所定义。
• ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE
  申请人：PTC THERAPEUTICS, INC.

  公开号：US20150038437A1

  公开（公告）日：2015-02-05

  The present description relates to compounds and forms and pharmaceutical compositions thereof and methods for use thereof to treat or ameliorate bacterial infections caused by wild-type and multi-drug resistant Gram-negative and Gram-positive pathogens.

  本说明涉及化合物和形式以及其制药组合物，以及使用它们治疗或改善由野生型和多重耐药革兰氏阴性和革兰氏阳性病原体引起的细菌感染的方法。
• COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES
  申请人：CHATTERJEE Arnab Kumar

  公开号：US20150291598A1

  公开（公告）日：2015-10-15

  The present invention provides compounds of formula I: [INSERT FORMULA HERE] or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease, such as malaria, caused by a Plasmodium parasite.

  本发明提供了I式化合物：[插入公式]或其药学上可接受的盐、互变异构体或立体异构体，其中变量的定义如本文所述。本发明还提供了包含这种化合物的药物组合物以及使用这种化合物治疗、预防、抑制、改善或根除由疟原虫引起的疾病，如疟疾的病理学和/或症状学的方法。